miR149-5p:一种包含微RNA的肝细胞外排序列,可通过特异性靶向肝星状细胞(HSCs)中的PDGFRB蛋白来抑制肝纤维化进程。
miR149-5p: A hepatocyte EXOmotif sequence containing microRNA that attenuates liver fibrosis by specifically targeting PDGFRB in HSCs
Ji-Chao Zhou, An-Jian Xu, Jing Miao, Rui-Bing Xu, Zhi-Meng Zhang, Ying-Li Fan, Jin-Mei Yu, Jiao-Jiao Yu, Hong-Yu Yuan, Ping-Ping Li, Bing Cui, Xiao-Wei Zhang
Journal:Journal of Advanced Research
IF:17.1
DOI:10.1016/j.jare.2026.08.021
PMID:42567345
Published:2026-08-07
research field:肿瘤学分子生物学癌症研究药物开发药理学
Abstract
Introduction Liver fibrosis is a progressive pathological process driven by liver injury, including viral hepatitis and metabolic dysfunction-associated steatohepatitis (MASH), and can progress to cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Hepatocyte–hepatic stellate cell (HSC) crosstalk plays a central role in disease progression, but its regulatory mechanisms remain incompletely understood. Objectives This study aimed to define hepatocyte–HSC crosstalk in liver fibrosis mediated by microRNA-149-5p (miR-149-5p) signaling and to explore its potential as a therapeutic target for intervention. Methods Differentially expressed exosomal microRNAs were identified by RNA sequencing of hepatocyte-derived exosomes from fibrotic and control livers. Functional screening using collagen type I alpha 1 chain (COL1A1) reporter assays identified miR-149-5p as an anti-fibrotic candidate. Exosome-mediated intercellular communication was confirmed using co-culture systems and confirmed by tumor susceptibility 101 (TSG101) silencing. Liver fibrosis was induced by bile duct ligation (BDL) and thioacetamide (TAA) in mice. Therapeutic effects were evaluated using AAV-mediated hepatocyte-specific overexpression and miR-149-5p agomir administration. Results miR-149-5p was selectively enriched in hepatocyte-derived exosomes via a CCUC-based EXOmotif and directly targeted PDGFRB in HSCs, thereby inhibiting HSC activation, proliferation, and collagen deposition without affecting hepatocyte function. During fibrosis progression, PU.1 bound to the miR-149-5p promoter and suppressed its transcription, leading to reduced exosomal miR-149-5p delivery and consequent PDGFRB derepression in HSCs. Both AAV-mediated overexpression and systemic miR-149-5p agomir administration significantly attenuated BDL- and TAA-induced liver fibrosis, as evidenced by reduced collagen deposition, decreased hydroxyproline content, and downregulation of HSC activation markers. Conclusion The PU.1 (
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


